A Bloomberg Terminal For DNA Sequencing
Forbes staff, Matthew Herper, compares the knoSYS to a Bloomberg terminal in an article on October 1, 2012. An excerpt:
[The knoSYS] is essentially a realization that sometimes experts want particular types of data a few steps away, putting the DNA analysis service business Knome is already running in a box.
Knome’s shift presents a snapshot of DNA sequencing at a moment when it is finally making its way into the clinic, even, in some cases, being paid for by insurance companies, and a raft of start-ups are trying to push their way into what seems to be a new medical ecosystem at the same time as the last round of entrants are struggling (see: Pacific Biosciences of California) or getting bought out cheap (Complete Genomics, acquired by China‘s BGI for just $117 million.)
Read the full article.